TAGLN and nonpapillary renal cell carcinoma: The function of the key protein, transgelin, was studied using CRISPR/Cas9 and RNA interference (RNAi) in cell lines derived from ccRCC tumors to confirm its role in RCC tumor development and sunitinib resistance.